Medication info
Podiem Tablet 1/250 Milligrams

Podiem Tablet 1/250 Milligrams

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›250mg / 1 tabletGlimepiride›1mg / 1 tablet
Manufacturer / importer
Daehwa Pharmaceutical Co., Ltd.
Appearance
White, rectangular film-coated tablet
Packaging
30 tablets/box (10 tablets/blister x 3), 300 tablets/bottle
Approval status
Active

MFDS item code 201107276 · Approved 2011.09.28 · Insurance code 645604030

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Take this medicine 1~2 times daily immediately before or with meals. The dose may be adjusted based on each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is usually initiated at a low dose, and the dose may be adjusted based on the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose of this medicine was glimepiride/metformin hydrochloride 2mg/500mg, and there is experience with gradually increasing the dose according to blood glucose monitoring results up to glimepiride/metformin hydrochloride 8mg/2000mg. Glimepiride as a single agent generally provides little additional benefit at doses above 4mg per day, although some patients achieved better metabolic control when the dose was increased to 6mg (or 8mg). When used as a substitute for combination therapy, administer based on the dosage regimen of glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than one dose at the next scheduled administration.

Ingredients

Manufacturer
Daehwa Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

View approved original text

This medication is used to assist patients with type 2 diabetes in controlling their blood sugar levels. Taking this medication while adhering to a dietary regimen and exercise can effectively manage blood sugar levels. Glymepiride and Metformin work together to help maintain blood sugar more stably. It plays an important role in diabetes management and enhances the patient's blood sugar control.

How to take

Adult dose

Take this medicine 1~2 times daily immediately before or with meals. The dose may be adjusted based on each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is usually initiated at a low dose, and the dose may be adjusted based on the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose of this medicine was glimepiride/metformin hydrochloride 2mg/500mg, and there is experience with gradually increasing the dose according to blood glucose monitoring results up to glimepiride/metformin hydrochloride 8mg/2000mg. Glimepiride as a single agent generally provides little additional benefit at doses above 4mg per day, although some patients achieved better metabolic control when the dose was increased to 6mg (or 8mg). When used as a substitute for combination therapy, administer based on the dosage regimen of glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than one dose at the next scheduled administration.

Precautions

This medication can cause severe lactic acidosis or hypoglycemia, so it should be temporarily discontinued if there is a sudden decline in kidney function or symptoms of dehydration. Especially, patients with poor kidney function, severe liver dysfunction, pregnant or breastfeeding women, and those with acute metabolic acidosis should not take this medication. Patients with a high risk of hypoglycemia, such as those with poor nutritional status or irregular meals, reduced kidney function, or severe liver damage, should take this medication cautiously. Gastrointestinal disturbances (diarrhea, nausea, vomiting, etc.) may occur at the beginning of treatment; however, they are mostly temporary and can be reduced by taking the medication with meals. This medication lowers blood sugar, so if symptoms of hypoglycemia (headache, dizziness, trembling, etc.) occur, sugar must be consumed immediately and a doctor should be consulted. Rare complications such as lactic acidosis may occur; if symptoms such as weakness, muscle pain, respiratory distress, or abdominal pain appear, the medication should be stopped immediately and the healthcare provider should be notified. Dosage should be adjusted according to kidney function, and it is important to receive regular kidney function tests. Additionally, there may be interactions with other medications, so all medications currently taken should be reported to healthcare providers, and it is advisable to avoid alcohol. Pregnant or breastfeeding women should not take this medication and should switch to insulin therapy if necessary. Children and the elderly require special attention as the safety and efficacy of this medication have not been sufficiently established.

Side effects

lactic acidosis, hypoglycemia, diarrhea, nausea, vomiting, abdominal distension, loss of appetite, dyspepsia, constipation, abdominal pain, metallic taste, visual impairment, taste disorder, erythema, itching, urticaria, thrombocytopenia, leukopenia, hemolytic anemia, anemia, agranulocytosis, pancytopenia, peripheral neuropathy due to vitamin B12 deficiency, elevated liver enzymes, liver function impairment, bile secretion disorder, jaundice, hepatitis, allergic vasculitis, photosensitivity, decreased serum sodium concentration, decreased thyroid-stimulating hormone levels, magnesium deficiency due to diarrhea, encephalopathy, hair loss, weight gain, abdominal pain, abdominal distension, palpitations, dizziness, vomiting, dyspepsia, leg edema, cardiac arrest, rectal carcinoma, dizziness, abnormal liver function, arthralgia, facial edema, erectile dysfunction, facial flushing, gastritis, headache, severe hunger, fatigue, sleep disturbance, instability, aggression, attention deficit, inability to concentrate, abnormal reaction, depression, confusion, speech disorder, aphasia, tremor, paralysis, sensory impairment, dizziness, inability to self-regulate, delirium, cerebral seizures, loss of consciousness, coma, weak respiration, slow pulse, sweating, moist skin, anxiety, rapid pulse, hypertension, angina pectoris, deep vein thrombosis, stroke, pancreatitis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container that prevents air from entering, ideally at room temperature between 1 degree and 30 degrees Celsius. Proper storage will help maintain the effectiveness of the medication and prevent degradation.

Appearance and packaging

Appearance

White, rectangular film-coated tablet

Package unit

30 tablets/box (10 tablets/blister x 3), 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.